UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Power Transformation Toward a Linear Regression Quantile

Journal of the American Statistical Association, 2007-03, Vol.102 (477), p.269-279

2007

Volltextzugriff (PDF)

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.16-17

2020

Volltextzugriff (PDF)

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-03, Vol.22 (2), p.300-311

2023

Volltextzugriff (PDF)

Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents

Current medical research and opinion, 2019-08, Vol.35 (8), p.1433-1440

2019

Volltextzugriff (PDF)

A DYNAMIC QUANTILE REGRESSION TRANSFORMATION MODEL FOR LONGITUDINAL DATA

Statistica Sinica, 2009-07, Vol.19 (3), p.1137-1153

2009

Volltextzugriff (PDF)

Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS MULTI (ON) inhibitor

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.591-591

2022

Volltextzugriff (PDF)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

Journal of managed care & specialty pharmacy, 2015-12, Vol.21 (12), p.1106-1114

2015

Volltextzugriff (PDF)

TRENDS IN CONVENTIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS AMONG U.S. ADULTS WITH TYPE II DIABETES OR PRE-DIABETES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 1999-2010

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1491-E1491

2013

Volltextzugriff (PDF)

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Clinical nutrition ESPEN, 2020-12, Vol.41, p.293-298

2020

Volltextzugriff (PDF)

Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Clinical nutrition ESPEN, 2021-02, Vol.41, p.293-298

2021

Volltextzugriff (PDF)

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Blood, 2017-12, Vol.130 (Suppl_1), p.89-89

2017

Volltextzugriff (PDF)

Practical Confidence Intervals for Regression Quantiles

Journal of computational and graphical statistics, 2005-03, Vol.14 (1), p.41-55

2005

Volltextzugriff (PDF)

AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S177-S177

2020

Volltextzugriff (PDF)

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.PR014-PR014

2023

Volltextzugriff (PDF)

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.526-526

2023

Volltextzugriff (PDF)

Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects

Stroke (1970), 2016-02, Vol.47 (suppl_1)

2016

Volltextzugriff (PDF)

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3597-3597

2022

Volltextzugriff (PDF)

Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies

Contemporary clinical trials, 2015-03, Vol.41, p.211-218

2015

Volltextzugriff (PDF)

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer

Clinical lung cancer, 2008-09, Vol.9 (5), p.306-306

2008

Volltextzugriff (PDF)

Power transformation towards linear or partially linear quantile regression models

Mu, Yunming

2005

Volltextzugriff (PDF)

Prototype Sodium-Ion Batteries Using an Air-Stable and Co/Ni-Free O3-Layered Metal Oxide Cathode

Advanced materials (Weinheim), 2015-11, Vol.27 (43), p.6928-6933

2015

Volltextzugriff (PDF)

A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer

Frontiers in oncology, 2020-04, Vol.10, p.457-457

2020

Volltextzugriff (PDF)

Air‐Stable Copper‐Based P2‐Na7/9Cu2/9Fe1/9Mn2/3O2 as a New Positive Electrode Material for Sodium‐Ion Batteries

Advanced science, 2015-06, Vol.2 (6), p.1500031-n/a

2015

Volltextzugriff (PDF)

Fe-Based Tunnel-Type Na0.61[Mn0.27Fe0.34Ti0.39]O2 Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Advanced energy materials, 2015-11, Vol.5 (22), p.n/a

2015

Volltextzugriff (PDF)

Fe‐Based Tunnel‐Type Na 0.61 [Mn 0.27 Fe 0.34 Ti 0.39 ]O 2 Designed by a New Strategy as a Cathode Material for Sodium‐Ion Batteries

Advanced energy materials, 2015-11, Vol.5 (22)

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(31)
Dissertationen
(1)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Physical Sciences
(8)
Life Sciences & Biomedicine
(7)
Energy Storage
(5)
Sodium-Ion Batteries
(5)
Anode
(4)
Chemistry
(4)
Kathode
(4)
Materials Science
(4)
Materials Science, Multidisciplinary
(4)
Mathematics
(4)
Natrium
(4)
Rechargeable Batteries
(4)
Statistics & Probability
(4)
Technology
(4)
Chemistry, Physical
(3)
Copper Redox Couple
(3)
Energiespeicherung
(3)
Humans
(3)
Kohlenstoff
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Power Transformation Toward a Linear Regression Quantile

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents

A DYNAMIC QUANTILE REGRESSION TRANSFORMATION MODEL FOR LONGITUDINAL DATA

Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS MULTI (ON) inhibitor

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

TRENDS IN CONVENTIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS AMONG U.S. ADULTS WITH TYPE II DIABETES OR PRE-DIABETES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 1999-2010

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Practical Confidence Intervals for Regression Quantiles

AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer

Power transformation towards linear or partially linear quantile regression models

Prototype Sodium-Ion Batteries Using an Air-Stable and Co/Ni-Free O3-Layered Metal Oxide Cathode

A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer

Air‐Stable Copper‐Based P2‐Na7/9Cu2/9Fe1/9Mn2/3O2 as a New Positive Electrode Material for Sodium‐Ion Batteries

Fe-Based Tunnel-Type Na0.61[Mn0.27Fe0.34Ti0.39]O2 Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Fe‐Based Tunnel‐Type Na 0.61 [Mn 0.27 Fe 0.34 Ti 0.39 ]O 2 Designed by a New Strategy as a Cathode Material for Sodium‐Ion Batteries

Aktive Filter

Suchergebnisse filtern